1-1 of 1
Andrew Bender
Close
Sort by
Journal Articles

M7583 Is a Highly Selective and Potent Second Generation BTK Inhibitor for Treatment of B-Cell Malignancies

Samantha M. Goodstal, PhD, Jianguo Ma, Jing Lin, Timothy Crandall, Lindsey Crowley, Andrew Bender, Riham Iadevaia, Anderson Clark
Journal: Blood
Blood (2017) 130 (Supplement 1): 3845.
https://doi.org/10.1182/blood.V130.Suppl_1.3845.3845
Published: 2017